$77.2 Thousand
21.2 Thousand
0.00%
$4.31
Prem Watsa's position in Revance Therapeutics is currently worth $77.2 Thousand. That's 0.00% of their equity portfolio (31st largest holding). The investor's estimated purchase price is $91.2 Thousand, resulting in a loss of 15%.
Easily embed the chart on your blog or website – it will always update automatically!